Aditxt, Inc., a biotechnology company, has responded to a comment from the U.S. Securities and Exchange Commission (SEC) regarding its Amendment No. 2 to the Registration Statement on Form S-1, initially filed on February 12, 2024. The SEC sought clarification on why Aditxt does not consider its merger with Evofem Biosciences, Inc. probable at this time. Aditxt outlined several unmet conditions that cast doubt on the merger's likelihood, including the conversion of Evofem's preferred stock, agreements with warrant holders, waivers from convertible noteholders, and an exchange of securities valued at approximately $86.1 million. Additionally, Aditxt has not yet secured funding for a required $3 million loan to Evofem, which is a condition for the merger. The company also disclosed that it is in default on secured notes due to a missed payment and is in negotiations to resolve the default, which could impact its financial stability and the merger's completion. Aditxt has amended its Form 8-K to remove references to financial statements and pro forma financial information related to the merger.

Aditxt, Inc., a biotechnology company, has responded to a comment from the U.S. Securities and Exchange Commission (SEC) regarding its Amendment No. 2 to the Registration Statement on Form S-1, initially filed on February 12, 2024. The SEC sought clarification on why Aditxt does not consider its merger with Evofem Biosciences, Inc. probable at this time. Aditxt outlined several unmet conditions that cast doubt on the merger's likelihood, including the conversion of Evofem's preferred stock, agreements with warrant holders, waivers from convertible noteholders, and an exchange of securities valued at approximately $86.1 million. Additionally, Aditxt has not yet secured funding for a required $3 million loan to Evofem, which is a condition for the merger. The company also disclosed that it is in default on secured notes due to a missed payment and is in negotiations to resolve the default, which could impact its financial stability and the merger's completion. Aditxt has amended its Form 8-K to remove references to financial statements and pro forma financial information related to the merger.